Mesothelioma and Our Hopes for Its Future

While 80% of rare diseases are genetic in origin, the remaining 20% are related to the environment or infection. This week’s blog, written by Tonya Nelson and her colleagues at Mesothelioma and Asbestos Awareness Center, introduces us to one such rare disease...

Can’t see the wood for the trees

This week’s blog comes from Gawain Paling, a founding member of Mast Cell Action, a charity set up to advance the cause of sufferers of Mast Cell Activation Disorders. In this post he shares his story to diagnosis. In the medical literature it is estimated that...

CRISPR/Cas9: The hero we deserve?

For many years, we have been promised that medical innovation will one day allow us to edit the human genetic code, to remove harmful mutations in our DNA, and wipe out genetic diseases. At last, CRISPR/Cas9 has been hailed as the hero that will finally allow us to do...

Medicine beyond the textbook: Pharmacology

[row][two-third] ‘Pharmacology’ is the third part  of Jessica Grace’s ‘Medicine beyond the textbook’ blog series. The blog posts, released every two months, share Jessica’s stories and thoughts as both a medical student and rare disease patient. Pharmacology is a...